The structure, regulation, and function of human matrix metalloproteinase-13

Critical Reviews in Biochemistry and Molecular Biology

Volumn 37, Issue 3, 2002, Pages 149-166

  Leeman, Matthew F ^a   Curran, Stephanie ^a   Murray, Graeme I ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CYTOKINE; ENZYME; GROWTH FACTOR; HORMONE; PROTEINASE; ZINC;

BONE METABOLISM; BREAST CARCINOMA; CANCER INVASION; CARTILAGINOUS TISSUE; CATALYSIS; CELL LINE; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; FEMALE GENITAL SYSTEM; GENITAL TRACT CANCER; HEAD AND NECK CARCINOMA; HOMEOSTASIS; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

COLLAGENASES; CYTOKINES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 13; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

EID: 0036063760     PISSN: 10409238     EISSN: None     Source Type: Journal    
DOI: 10.1080/10409230290771483     Document Type: Review

References (70)

1. Matrix metalloproteinases in tumour invasion and metastasis
2. Matrix metalloproteinases: Molecular aspects of their roles in tumour invasion and metastasis
3. Matrix metalloproteinases: A multifunctional group of molecules
4. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
5. The human collagenase-3 (CLG) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family
6. Structural analysis and promoter characterisation of the human collagenase-3 gene (MMP-13)
7. Cloning, sequencing and characterisation of the 5′-flanking region of the human collagenase-3 gene
8. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites
9. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene
10. TGF-β1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence
11. Developmental regulation of collagenase-3 mRNA in normal, differentiating osteoblasts through the activator protein-1 and the runt domain binding sites
12. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation
13. Skeletal bone morphogenetic proteins suppress the expression of collagenase-3 by rat osteoblasts
14. Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures
15. Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B
16. Transcriptional induction of matrix metalloproteinase-13 (collagenase-3) by 1α,25-dihydroxyvitamin D3 in mouse osteoblastic MC3T3-E1 cells
17. Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence
18. AP-1 and Cbfa/Runt physically interact and regulate PTH-Dependent MMP13 expression in osteoblasts through a new OSE-2/AP-1 composite element
19. Autocrine down-regulation of collagenase-3 in rat bone cell cultures by insulin-like growth factors
20. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase- 1, -3, -8 and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin m in combination with interleukin 1α
21. Platelet-derived growth factor induces collagenase 3 transcription in osteoblasts through the activator protein 1 complex
22. Basic fibroblast growth factor stimulates collagenase-3 promoter activity in osteoblasts through an activator protein-1-binding site
23. Transforming growth factor β1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures
24. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor
25. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase
26. Modulation of collagenase 3 in human osteoarthritic cartilage by activation of extracellular transforming growth factor β. Role of furin convertase
27. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage. Involvement of the stress-activated protein kinase/c-jun n-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade
28. Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13)
29. Regulation of matrix metalloproteinases (MMP-2, -3, 9 and -13) by interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption
30. Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes
31. Interleukin-1 induction of collagenase 3 (Matrix Metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor κB
32. Peroxisome proliferator-activated receptor γ activators inhibit interleukin-1β-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes
33. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions
34. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase
35. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus Kinase/STAT signalling pathway
36. The helping hand of collagenase-3 (MMP-13): 2.7 crystal structure of its c-terminal haemopexin-like domain
37. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity
38. A helping hand for collagenases: The haemopexin-like domain
39. Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors
40. High-resolution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor
41. Biochemical characterisation of human collagenase-3
42. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme
43. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: Associated activation of gelatinase a, gelatinase b and collagenase 3
44. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13)
45. Regulation of the collagenase-3 receptor and its role in intracellular ligand processing in rat osteoblastic cells
46. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization
47. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
48. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity and tissue inhibitor of metalloproteinase interaction
49. Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases
50. Degradation of cartilage aggrecan by collagenase-3 (MMP-13)
51. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparinases
52. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library
53. Authentic matrix vesicles contain active metalloproteinases (MMP). A role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-β
54. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumour invasion and angiogenesis
55. Fibrillin degradation by matrix metalloproteinases: Implications for connective tissue remodelling
56. Kinetics and physiologic relevance of the inactivation of α1-protease inhibitor, α1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDA gelatinase/type iv collagenase), and -3 (stromelysin)
57. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII
58. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development
59. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis
60. Expression of most matrix metalloproteinase family members in breast cancer represents a tumour-induced host response
61. A switch from stromal to tumour cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumour progression
62. Expression and regulation of collagenase-3 (MMP-130 in human malignant tumours
63. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness
64. Expression of collagenase-3 (matrix metalloproteinase 13) in squamous cell carcinomas of the head and Nneck
65. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx
66. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas
67. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas
68. Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: Comparison with normal skin
69. Human collagenase-3 is expressed in malignant squamous epithelium of the skin
70. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice